Pfizer Announces Positive Late Stage Trial of Cancer Treatment
Pfizer shares were rising Thursday morning.

Pfizer Inc. (PFE) shares were slightly higher in morning trading Thursday after the company announced positive results from its late stage trials of prostate cancer treatment candidate Xtandi. 

The trial was conducted in conjunction with Astellas Pharma Inc. (ALPMF) and found that Xtandi, when combined with a standard prostate cancer therapy, improved survival rates relative to just standard prostate treatments on its own. 

There are currently no FDA-approved treatments for patients with non-metastatic castration-resistant prostate cancer. 

More of What's Trending on TheStreet:

More from Stocks

Dow Trades Higher, Nasdaq Regains Footing as Chipmakers Fall

Dow Trades Higher, Nasdaq Regains Footing as Chipmakers Fall

Chip Stocks May Have Sold Off Too Much On Recent Spate of Bad News

Chip Stocks May Have Sold Off Too Much On Recent Spate of Bad News

Walmart Bulls Ring up Profits After Earnings Beat

Walmart Bulls Ring up Profits After Earnings Beat

Tesla Has Lost 15% Since Musk's Take-Private Tweet

Tesla Has Lost 15% Since Musk's Take-Private Tweet

Here's How to Trade Walmart, Nordstrom, Macy's and JCPenney After Earnings

Here's How to Trade Walmart, Nordstrom, Macy's and JCPenney After Earnings